Short-term oral oleoyl-estrone treatment increases plasma cholesterol turnover in the rat

International Journal of Obesity

Volumn 29, Issue 5, 2005, Pages 534-539

  Cabot, C ^a   Salas, A ^a   Ferrer Lorente, R ^a   Savall, P ^a   Remesar, X ^a   Fernandez Lopez J A ^a   Esteve, M ^a   Alemany, M ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Cholesterol turnover; Cholesteryl esters; Insulin resistance; Oleoyl estrone

Indexed keywords

3 HYDROXYBUTYRIC ACID; CHOLESTEROL ESTER; ESTRONE DERIVATIVE; ESTRONE OLEATE; FATTY ACID; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; SUNFLOWER OIL; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BLOOD ANALYSIS; BODY FAT; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL METABOLISM; CONTROLLED STUDY; DRUG ACTIVITY; FEEDING; FEMALE; FOOD INTAKE; INSULIN RESISTANCE; INSULIN SENSITIVITY; METABOLITE; NONHUMAN; PRIORITY JOURNAL; RAT; RAT STRAIN;

ADMINISTRATION, ORAL; ANIMALS; ANTI-OBESITY AGENTS; BLOOD GLUCOSE; BODY WEIGHT; CHOLESTEROL; CHOLESTEROL, HDL; DRUG ADMINISTRATION SCHEDULE; EATING; ESTRONE; FEMALE; INSULIN; LIPIDS; OLEIC ACIDS; RATS; RATS, WISTAR;

EID: 17844367338     PISSN: 03070565     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ijo.0802898     Document Type: Article

References (23)

1. Sanchis D, Balada F, Grasa MM, Virgili J, Peinado J, Monserrat C, Fernández-López JA, Remesar X, Alemany M. Oleoyl-estrone induces the loss of body fat in rats. Int J Obes Relat Metab Disord 1996; 20: 588-594.
2. Grasa MM, Cabot C, Esteve M, Yubero P, Masanés RM, Blay M, Vilà R, López-Martí J, Fernández-López JA, Remesar X, Alemany M. Daily oral oleoyl-estrone gavage induces a dose-dependent loss of fat in Wistar rats. Obes Res 2001; 9: 202-209.
3. Blay M, Peinado-Onsurbe J, Grasa MM, Díaz-Silva M, Fernández-López JA, Remesar X, Alemany M. Effect of oral oleoyl-estrone treatment on plasma lipoproteins and tissue lipase and lipase activities of Zucker lean and obese female rats. Int J Obes Relat Metab Disord 2002; 26: 618-626.
4. Sanchis D, Balada F, Picó C, Grasa MM, Virgili J, Farrerons C, Palou A, Fernández-López JA, Remesar X, Alemany M. Rats receiving the slimming agent oleoyl-estrone in liposomes (Merlin-2) decrease food intake but maintain thermogenesis. Arch Physiol Biochem 1997; 105: 663-672.
5. Sanchis D, Adán C, Ardévol A, Grasa MM, Cabot C, Balada F, Vilà R, Estruch J, Puerta ML, Fernández-López JA, Remesar X, Alemany M. Short-term treatment with oleoyl-estrone in liposomes (Merlin-2) strongly reduces the expression of the ob gene in young rats. Biochem J 1997; 326: 357-3608.
6. Adán C, Cabot C, Esteve M, Grasa MM, Masanés R, Vilà R, Estruch J, Fernández-López JA, Remesar X, Alemany M. Oleoyl-estrone treatment affects the ponderostat setting differently in lean and in obese Zucker rats. Int J Obes Relat Metab Disord 1999; 22: 366-373.
7. Remesar X, Fernández-López JA, Blay MT, Savall P, Salas A, Díaz-Silva M, Esteve M, Grasa MM, Alemany M. Effect of oral oleoyl-estrone on adipose tissue composition in male rats. Int J Obes Relat Metab Disord 2002; 26: 1092-1102.
8. Remesar X, Guijarro P, Torregrosa C, Grasa MM, López J, Fernández-López JA, Alemany M. Oral oleoyl-estrone induces the rapid loss of body fat in Zucker lean rats fed a hyperlipidic diet. Int J Obes Relat Metab Disord 2000; 24: 1405-1412.
9. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Teacher DF, Turner RC. Homeostasis model assessment: insulin resistance and B cell function from fasting plasma glucose and insulin concentration in man. Diabetologia 1985; 28: 412-419.
10. Bonora E, Saggiani F, Targher G, Zenere MB, Alberiche M, Monauni T, Bonadonna RC, Muggeo M. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity. Diabetes Care 2000; 23: 57-63.
11. Dell RB, Mott GE, Jackson EM, Ramakrishnan R, Carey KD, McGill HC, Goodman DWS. Whole body and tissue cholesterol turnover in the baboon. J Lipid Res 1985; 26: 327-337.
12. Robins SJ, Fasulo JM, Collins MA, Patton GM. Cholesterol exchange and synthesis in the live rat. J Lipid Res 1985; 26: 1230-1240.
13. Folch J, Lees M, Sloane-Stanley GH. A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem 1957; 232: 497-509.
14. Touchstone JC. Thin layer chromatographic procedures for lipid separation. J Chromatogr B 1995; 671: 169-195.
15. Hobbs JT. Total blood volume: its measurement and significance. Medical Monographs. The Radiochemical Centre: Amersham; 1987.
16. Ferreira LDMC, Pulawa LK, Jensen DR, Eckel RH. Overexpressing human lipoprotein lipase in mouse skeletal muscle is associated with insulin resistance. Diabetes 2001; 50: 1064-1068.
17. Ruotolo G, Howard BV. Dyslipemia of the metabolic syndrome. Curr Cardiol Rep 2002; 4: 494-500.
18. Pihlajamäki J, Gylling H, Miettinen TA, Laakso M. Insulin resistance is associated with increased cholesterol synthesis and decreased cholesterol absorption in normoglycemic men. J Lipid Res 2004; 45: 507-512.
19. Couillard C, Lamarche B, Tchernof A, Prud'homme D, Tremblay A, Bouchard C, Moorjani S, Nadeau A, Lupien PJ, Després JP. Plasma high-density lipoprotein cholesterol but not apolipoprotein A-I is a good correlate of the visceral obesity-insulin resistance dyslipidemic syndrome. Metabolism 1996; 45: 882-888.
20. Ohnishi H, Saitoh S, Takagi S, Ohata J, Isobe T, Kikuchi Y, Takeuchi H, Shimamoto K. Relationship between insulin-resistance and remnant-like particle cholesterol. Atherosclerosis 2002; 164: 167-170.
21. Chan DC, Watts GF, Barrett PHR, O'Neill FH, Redgrave TG, Thompson GR. Relationships between cholesterol homoeostasis and triacylglycerol-rich lipoprotein remnant metabolism in the metabolic syndrome. Clin Sci 2003; 104: 383-388.
22. Panarotto D, Remillard P, Bouffard L, Maheux P. Insulin resistance affects the regulation of lipoprotein lipase in the postprandial period and in an adipose tissue-specific manner. Eur J Clin Invest 2002; 32: 84-92.
23. Riemens SC, van Tol A, Scheek LM, Dullaart RPF. Plasma cholesteryl ester transfer and hepatic lipase activity are related to high-density lipoprotein cholesterol in association with insulin resistance in type 2 diabetic and non-diabetic subjects. Scand J Clin Lab Invest 2001; 61: 1-9.